Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)
China flag China · Delayed Price · Currency is CNY
21.74
-0.71 (-3.16%)
Sep 2, 2026, 3:04 PM CST

SHE:002880 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
183.06246.32253.52218.65117.52205.44
Depreciation & Amortization
158.1153.1118.2787.3165.2655.48
Other Amortization
6.566.32.172.131.591.29
Loss (Gain) From Sale of Assets
---0.05--0.04-
Asset Writedown & Restructuring Costs
-0.010.04-0.10.10.430.32
Loss (Gain) From Sale of Investments
-8.49-6.638.53-7.8-18.68-0.74
Provision & Write-off of Bad Debts
13.8525.424.08-2.5-1.341.11
Other Operating Activities
20.3720.7724.4612.956.523.1
Change in Accounts Receivable
-345.92-330.44-144.4888.2133.52-2.72
Change in Inventory
-115.13-92.87-119.9-50.56-183.83-37.76
Change in Accounts Payable
190.3239.4535.0135.62-20.0620.25
Change in Other Net Operating Assets
15.2315.23-3.5120.86--
Operating Cash Flow
108.87263.18177.77397.941.2246.89
Operating Cash Flow Growth
-22.83%48.05%-55.33%33088.09%-99.51%-18.78%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-170.08-169.69-255.5-328.85-327.37-240.83
Sale of Property, Plant & Equipment
0.090.040.170.070.120.23
Cash Acquisitions
----22.39--
Investment in Securities
-32.97-10015-1-160-49.48
Other Investing Activities
0.7214.732.13--0-
Investing Cash Flow
-202.24-254.92-238.2-352.17-487.26-290.08

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-182.55----
Long-Term Debt Issued
-421.31252.76179.97528.4875
Total Debt Issued
799.57603.87252.76179.97528.4875
Long-Term Debt Repaid
--452.14-93.16-202.55-26.39-133.35
Total Debt Repaid
-652.14-452.14-93.16-202.55-26.39-133.35
Net Debt Issued (Repaid)
147.43151.72159.6-22.58502.09-58.35
Issuance of Common Stock
-----4
Common Dividends Paid
-108.17-65.73-65.88-65.6-57.68-41.82
Other Financing Activities
---10-3.5-
Financing Cash Flow
39.2685.9983.72-88.18447.9-96.18

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Cash Flow
-54.1194.2523.29-42.41-38.16-139.37

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-61.2193.49-77.7369.08-326.176.06
Free Cash Flow Growth
------94.72%
Free Cash Flow Margin
-5.11%7.38%-6.46%6.59%-48.83%0.67%
Free Cash Flow Per Share
-0.270.41-0.340.30-1.440.03
Levered Free Cash Flow
-182.1415.6-150.4312.4-372.74-22.58
Unlevered Free Cash Flow
-169.8728.65-136.7221.36-371.45-21.41

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Interest Paid
----1.11-
Cash Income Tax Paid
137.71107.1785.1272.1516.2571.17
Change in Working Capital
-264.57-182.13-233.1287.09-170.05-19.12